Role of RANK ligand in mediating increased bone resorption in early postmenopausal women
Open accessThe DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Abstract
Studies in rodents have implicated various cytokines as paracrine mediators of increased osteoclastogenesis during estrogen deficiency, but increases in RANKL, the final effector of osteoclastogenesis, have not been demonstrated. Thus, we isolated bone marrow mononuclear cells expressing RANKL on their surfaces by two-color flow cytometry using FITC-conjugated osteoprotegerin-Fc (OPG-Fc-FITC) as a probe. The cells were characterized as preosteoblastic marrow stromal cells (MSCs), T lymphocytes, or B lymphocytes by using Ab's against bone alkaline phosphatase (BAP), CD3, and CD20, respectively, in 12 premenopausal women (Group A), 12 early postmenopausal women (Group B), and 12 age-matched, estrogen-treated postmenopausal women (Group C). Fluorescence intensity of OPG-Fc-FITC, an index of the surface concentration of RANKL per cell, was increased in Group B over Groups A and C by two- to threefold for MSCs, T cells, B cells, and total RANKL-expressing cells. Moreover, in the merged groups, RANKL expression per cell correlated directly with the bone resorption markers, serum C-terminal telopeptide of type I collagen and urine N-telopeptide of type I collagen, in all three cell types and inversely with serum 17beta-estradiol for total RANKL-expressing cells. The data suggest that upregulation of RANKL on bone marrow cells is an important determinant of increased bone resorption induced by estrogen deficiency.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In humans, estrogen deficiency is associated with an expansion of RANKL-and TNF-expressing T cells and B cells (27,28,30,31).”
From Sex steroid deficiency-associated bone loss is microbiota dependent and prevented by probiotics (2016) · cites this paper as [27]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“RANKL levels were increased on the surface of bone marrow cells from early postmenopausal women who are estrogen deficient”
From Pathogenesis of osteoporosis: concepts, conflicts, and prospects (2005) · cites this paper as [48]
In the citing paper
“Moreover, estrogen stimulates these bone cells to produce osteoprotegerin (OPG), a decoy receptor of RANK in osteoclast, thus inhibiting osteoclastogenesis [19, 155–159].”
From Biology of Bone Tissue: Structure, Function, and Factors That Influence Bone Cells (2015) · cites this paper as [157]
In the citing paper
“In humans, estrogen deficiency is associated with increased RANKL expression by bone marrow osteoblastic, T and B cells, whereas estrogen treatment reversed this increase ( 76).”
From Receptor Activator of Nuclear Factor κB Ligand and Osteoprotegerin Regulation of Bone Remodeling in Health and Disease (2008) · cites this paper as [76]
In the citing paper
“flow cytometry studies conducted with bone marrow aspirates from postmenopausal subjects showed that saturating levels of OPG did not reduce the ability of anti-TRAIL antibodies to recognize TRAIL-positive cells (76).”
From Receptor Activator of Nuclear Factor κB Ligand and Osteoprotegerin Regulation of Bone Remodeling in Health and Disease (2008) · cites this paper as [76]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation.
Lacey, D. L., Timms, E., Tan, H.-L., Kelley, M. J., Dunstan, C. R., Burgess, T., Elliott, R., Colombero, A., Elliott, G., Scully, S., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)81569-x · Cited by 5,439
Self-citationOsteoprotegerin: a novel secreted protein involved in the regulation of bone density.
Simonet, W. S., Lacey, D. L., Dunstan, C. R., Kelley, M., Chang, M.-S., Lüthy, R., Nguyen, H. Q., Wooden, S., Bennett, L., Boone, T., et al. (1997) · Cell · doi:10.1016/s0092-8674(00)80209-3 · Cited by 5,130
Self-citationYasuda, H., Shima, N., Nakagawa, N., Yamaguchi, K., Kinosaki, M., Mochizuki, S.-I., Tomoyasu, A., Yano, K., Goto, M., Murakami, A., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.7.3597 · Cited by 4,228
OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph node organogenesis.
Kong, Y.-Y., Yoshida, H., Sarosi, I., Tan, H.-L., Timms, E., Capparelli, C., Morony, S., Oliveira-dos-Santos, A. J., Van, G., Itie, A., et al. (1999) · Nature · doi:10.1038/16852 · Cited by 3,351 · cited 1×
“The expression of RANKL by T cells may be related, in part, to their function as immunoregulators, because targeted disruption of the RANKL gene results in mice lacking lymph nodes and with defective T and B lymphocyte differentiation (45).”
BackgroundSelf-citationManolagas, S. C. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.2.0395 · Cited by 2,568
Estrogen Resistance Caused by a Mutation in the Estrogen-Receptor Gene in a Man
Smith, E. P., Boyd, J., Frank, G. R., Takahashi, H., Cohen, R. M., Specker, B., Williams, T. C., Lubahn, D. B., & Korach, K. S. (1994) · New England Journal of Medicine · doi:10.1056/nejm199410203311604 · Cited by 2,471 · cited 1×
“For example, ERα knockout mice have short limbs and mild osteopenia (31), whereas a young adult male with homozygous null mutations of ERα had elongated limbs and a greater degree of osteopenia (32).”
BackgroundSuda, T., Takahashi, N., Udagawa, N., Jimi, E., Gillespie, M. T., & Martin, T. J. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.3.0367 · Cited by 2,336
Estrogen Receptor Null Mice: What Have We Learned and Where Will They Lead Us?
Couse, J. F., & Korach, K. S. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.3.0370 · Cited by 2,045
Kong, Y.-Y., Feige, U., Sarosi, I., Bolon, B., Tafuri, A., Morony, S., Capparelli, C., Li, J., Elliott, R., McCabe, S., et al. (1999) · Nature · doi:10.1038/46303 · Cited by 1,856 · cited 1×
“In an experimental mouse model of inflammatory arthritis, activated T lymphocytes expressing RANKL were shown to regulate the associated periarticular bone loss and joint destruction (46).”
BackgroundSelf-citationSex Steroids and the Construction and Conservation of the Adult Skeleton
Riggs, B. L., Khosla, S., & Melton, L. J. (2002) · Endocrine Reviews · doi:10.1210/edrv.23.3.0465 · Cited by 1,846
Self-citation
Research works printed but not linked: 8
- 10.1210/jc.87.4.1443 · doi:10.1210/jc.87.4.1443 · Paper page
- 10.1210/en.142.12.5050 · doi:10.1210/en.142.12.5050 · Paper page
- 10.1210/en.140.9.4367 · doi:10.1210/en.140.9.4367 · Paper page
- 10.1210/en.142.6.2205 · doi:10.1210/en.142.6.2205 · Paper page
- 10.1210/jc.87.4.1550 · doi:10.1210/jc.87.4.1550 · Paper page
- 10.1210/en.141.12.4768 · doi:10.1210/en.141.12.4768 · Paper page
- Owen, 1988, Ciba Found. Symp., 136, 42
- 10.1002/1521-4141(200208)32:8<2246::AID-IMMU2246>3.0.CO;2-6 · DOI
Cited by
Items 701–800 of 821
Weitzmann, M. N., & Pacifici, R. (2005) · Elsevier eBooks · doi:10.1016/b978-012183502-6/50007-9 · Cited by 3
Liu, J., Zhao, H., Ning, G., Zhao, Y., Chen, Y., Zh, L., Sun, L., Xu, Y., & Chen, J. L. (2005) · Cited by 1
Geroscience and Management of Osteoporosis in Older Adults
Miedany, Y. M. E. (2022) · Springer eBooks · doi:10.1007/978-3-030-87950-1_19 · Cited by 1
Guglielmi, G., Diano, D., Ponti, F., Nasuto, M., & Bazzocchi, A. (2013) · Springer eBooks · doi:10.1007/978-3-642-35579-0_3 · Cited by 1
Obesity and the Effects of Excess Adiposity on Bone Properties, Health, and Function
Taylor, L. A. (2015) · Pursuit The Journal of Undergraduate Research at the University of Tennessee · doi:10.7290/pur6ezyw · Cited by 2
“The fact that this menopause induced bone loss is also linked to the increased production of the pro-inflammatory cytokines that initiate the osteoclastic activity provides further evidence of this (Cao 2011; Eghbali-Fatourechi et al., 2003).”
BackgroundThe differential effects of two critical osteoclastogenesis stimulating factors on bone biomechanics
Yuan, Y. (2007) · TigerPrints (Clemson University) · Cited by 1
Martin, T. J., & Sims, N. A. (2006) · Elsevier eBooks · doi:10.1016/b9-78-012088-5/62650-0169 · Cited by 2
Risk factors for bone fragility and fracture in postmenopausal women
Svejme, O. (2013) · Lund University Publications (Lund University) · Cited by 2
Coetzee, M. (2006) · UpSpace Institutional Repository (University of Pretoria) · Cited by 1
Matsumoto, C., Miyaura, C., & Itô, A. (2004) · Eisei kagaku · doi:10.1248/jhs.50.309 · Cited by 1
Graef, J. L. (2016) · SHAREOK (University of Oklahoma; Oklahoma State University; Central Oklahoma University) · Cited by 1
Schurman, D. J., Maloney, W. J., & Smith, R. L. (2008) · Elsevier eBooks · doi:10.1016/b978-012370544-0.50060-4 · Cited by 2
Distant Immune and Microbiome Regulation
Pacifici, R. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.11232-2 · Cited by 1
Manolagas, S. C., & Almeida, M. (2018) · Wiley eBooks · doi:10.1002/9781119266594.ch26 · Cited by 3
On the Role of Osteoprotegerin/RANK/RANKL System in the Interaction between Prostate Cancer and Bone
Penno, H. (2011) · Uppsala University Publications (Uppsala University) · Cited by 3
β-Arrestin2 Regulates RANKL and Ephrins Gene Expression in Response to Bone Remodeling in Mice
Pierroz, D. D., Rufo, A., Bianchi, E. N., Glatt, V., Capulli, M., Rucci, N., Cavat, F., Rizzoli, R., Teti, A. M., Bouxsein, M., et al. (2009) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.081237 · Cited by 49
“River Laboratories, L’Arbresle, France), intermittently with daily subcutaneous injections of hPTH(1-34) (80 mg/ kg/d) or vehicle.”
BackgroundMethodInfluentialThe interrelationship of sex steroid levels, body composition and bone characteristics in men
Lapauw, B. (2009) · Ghent University Academic Bibliography (Ghent University)
Bedeutung von RANK-Ligand und Osteoprotegerin für den Knochenstoffwechsel
Hofbauer, L. C., & Schoppet, M. (2006) · Springer eBooks · doi:10.1007/3-540-28782-5_21 · Cited by 1
Pharmacological Treatment of Osteoporosis
Malouf, J., & Güerri‐Fernández, R. (2012) · InTech eBooks · doi:10.5772/30552
Feasible Simulation of Diseases Related to Bone Remodelling and of Their Treatment
Klika, V., & Maršík, F. (2011) · InTech eBooks · doi:10.5772/27682 · Cited by 1
Estrogen and raloxifene in experimental arthritis and osteoporosis
Jochéms, C. (2008) · Gothenburg University Publications Electronic Archive (Gothenburg University) · Cited by 3
A lymphoid enhancer binding factor (Lef) 1 isoform regulates osteoblast maturation.
Hoeppner, L. H. (2010) · University of Minnesota Digital Conservancy (University of Minnesota)
Ashley, D. T. (2010) · Dublin City University Open Access Institutional Repository (Dublin City University)
Dettmer, B. (2012) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-1528
THE FUNCTION OF NR3B AND NR4A ORPHAN NUCLEAR RECEPTORS IN OSTEOBLASTS
Rajalin, A.-M. (2011) · Helda - University of Helsinki Institutional Repository
Clinical and basic research papers: April 2003 selections
Seeman, E., & Strewler, G. J. (2003) · BoneKEy-Osteovision · doi:10.1138/2003091
Osteopenia and osteoporosis in HIV-infected patients
Gołaszewska, D., & Racewicz, A. J. (2007) · HIV & AIDS Review · doi:10.1016/s1730-1270(10)60072-0
Cancer treatment‐induced bone loss: A review
Barnett, F. S., & BOER, R. D. (2006) · Asia-Pacific Journal of Clinical Oncology · doi:10.1111/j.1743-7563.2006.00067.x
RANK-Fc Gene Therapy in Mouse Model of Osteoporosis
Chung, H. Y. (2006) · Journal of Korean Endocrine Society · doi:10.3803/jkes.2006.21.3.189
“폐경 후 골다공증[6], 스 테로이드에 의한 골다공증[7], 부갑상선기능항진증[8] 등과 같은 대사성골질환은 물론이며, 염증성 질환인 류마티스 관 절염[9], 그리고 다발성골수종[10] 및 골흡수성 골전이[11] 등과 같은 종양 질환에서도 RANKL의 발현 증가로 인한 골 흡수 증가를 설명할 수 있게 됨에 따라, RANKL이 파골세 포와 관련된 많은 질환에서 매우 중요한 역할을 수행하고 있음을 짐작하게 한다.”
Ertörer, M. E., Bakıner, O., Anaforoğlu, İ., Sezgin, N., Demirağ, N. G., & Tütüncü, N. B. (2007) · Current Therapeutic Research · doi:10.1016/j.curtheres.2007.08.001
review article Estrogen Therapy for Postmenopausal Osteoporosis
Fitzpatrick, L. A. (2006)
et cible thérapeutique dans l'ostéoporose
Marie, P. J., & Halbout, P. (2008)
Inflammatory Bowel Diseases and Skeletal Health
Sylvester, F. A. (2012) · Springer eBooks · doi:10.1007/978-1-4614-5061-0_13
Bertini, K., Drnovsek, M., Echin, M., Ercolano, M., Mingote, E., & Rubin, Z. (2014) · Cited by 1
Parathyroid Hormone in the Pathophysiology of Osteoporosis
Khosla, S. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-397166-1.00058-8
Self-citationAntibodies for the Treatment of Bone Diseases: Clinical Data
Winzer, M., Rauner, M., & Hofbauer, L. C. (2016) · Springer eBooks · doi:10.1007/978-3-319-34238-2_10
Gnerre, P., & Nardi, R. (2016) · Italian Journal of Medicine · doi:10.4081/itjm.q.2016.4
Use of Bone Biomarkers After Weight Loss: Example of Bariatric Surgery
Biagioni, M., Mendes, A. L., de Paiva, S. A. R., & Mazeto, G. M. F. D. S. (2015) · Biomarkers in disease · doi:10.1007/978-94-007-7745-3_8-1
Osteoporosis in Cholelithiasis: Biochemical Markers
Shari, F. H., Taher, M. A., & AL-Ahmedi, S. K. (2017)
Hofmann, A. (2017) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-6192
Understanding Injury, Health, and Adaptations of the Musculoskeletal System
O'Donnell, M. (2012) · Orthopaedic Section, APTA, Inc. eBooks · doi:10.17832/isc.2012.22.1.1
Osteoimmunology: An Evolving Discipline
(2013) · Journal of Arthritis · doi:10.4172/2167-7921.1000e108
“RANKL expression in early PM women triples the number of mononuclear cells in bone marrow, both in terms of preosteoblasts or T and B lymphocytes, compared with premenopausal or PM women treated with oestrogen replacement therapy [29,30].”
ResultMenapoz Osteoporozunda Östrojenin Kritik Rolü
Sharma, M., & Chandra, S. (2017) · Journal of Contemporary Medicine · doi:10.16899/gopctd.315052 · Cited by 1
El estado metabólico y su asociación con la actividad ósea en la mujer posmenopáusica
Pérez, N. C., Acevedo, M. L., García, R. P. S., Luna, A. K. R., Cruz, E. R., Arregoitia-Sarabia, C. K., Valencia, M. H., García, B. C. S., & Maldonado, E. R. (2017) · Clínica e Investigación en Ginecología y Obstetricia · doi:10.1016/j.gine.2017.10.001 · Cited by 1
Single Chain Fraction Variable Binding Molecules as Bone-Targeting Therapeutics and Diagnostics
Lam, M. (2011) · ERA: Education and Research Archive (University of Alberta) · doi:10.7939/r3fh1f
Diseases of Mineral Metabolism and Bone: Emerging Therapeutics for Postmenopausal Osteoporosiss
Miller, P. D. (2012) · Springer eBooks · doi:10.1007/978-1-4471-2745-1_9
“Rank-L, a glycoprotein produced in the osteoblast, is a member of the superfamily of ligands and is also known as TNF – activation-induced cytokine and osteoclast activator [ 11, 19, 68 ] .”
BackgroundPinho, J. P. D. (2013) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · doi:10.34626/bpcq-8675
Pathogenesis of Inflammation-Induced Bone Loss
Humphrey, M. B., & Nakamura, M. C. (2006) · Elsevier eBooks · doi:10.1016/b978-0-323-03437-1.50032-4
El hueso en la obesidad. Cirugía bariátrica y metabolismo mineral óseo
Sáez, J. M. G., García, D. F., & García, N. V. (2014) · Elsevier eBooks · doi:10.1016/b978-84-9022-503-5.00019-8
Romualdo, P. C. (2018) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.58.2018.tde-30082017-101105
The role of MSCS in immunoregulation of macrophages during osteogenesis
Huang, R. S. (2018) · Queensland University of Technology · doi:10.5204/thesis.eprints.123512
B Cells in The Regulation of Bone Metabolism
Grčević, D., Sanjay, A., & Lorenzo, J. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.11201-2
Park, S. H., Kim, Z.-O., Ji, Y. S., & Yoon, J. H. (2019) · Korean Journal of Sport Science · doi:10.24985/kjss.2019.30.3.449
Avances en el conocimiento de la fisiopatología ósea: Rank/Rankl/Osteoprotegerina
Doménech, R. M., de Salazar, J. C. R. G., & Soler, G. S. (2008) · Revista de la SVR: Sociedad Valenciana de Reumatología
Pathophysiology of osteoporosis
Streeten, E. A., Jaimungal, S., & Hochberg, M. C. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-09138-1.00199-6
Anatomy and Histology of Male Skeletal Tissue: Gender Differences
Grano, M., Brunetti, G., Colaianni, G., & Colucci, S. C. (2020) · Trends in andrology and sexual medicine · doi:10.1007/978-3-319-96376-1_2 · Cited by 1
Physiology of Bone Mass Acquisition and Pathophysiology of Bone Mass Loss: Gender Differences
Eller-Vainicher, C., Cairoli, E., & Chiodini, I. (2020) · Trends in andrology and sexual medicine · doi:10.1007/978-3-319-96376-1_3
ASSESSING STRUCTURAL AND MATERIAL PROPERTIES OF BONE FOLLOWING RADIATION THERAPY AND HEMARTHROSIS
Sullivan, L. (2020) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/k9hw-5s48
Maintained Bone Density in Young Hypoestrogenized Women with a High BMI: Case Series
Rivas, A. C., Burt, L. A., Innes, M., Boyd, S. K., & Kline, G. A. (2021) · Calcified Tissue International · doi:10.1007/s00223-021-00857-w
“In addition, in vivo studies have shown estrogen deficiency leads to an upregulation of RANKL protein expression in osteoblasts, T-cells and B-cells [10, 11].”
BackgroundClassificação e fisiopatologia da osteoporose
Lopes, J. B., & Pereira, R. M. R. (2012) · Revista Paulista de Reumatologia · doi:10.46833/reumatologiasp.2011.10.s1.21-29
Biology and Clinical Aspects of Estrogen Action on Bone
Monroe, D. G., & Khosla, S. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.11272-3
Self-citationGeneva-Popova, M. G., Rheumatology, U. "., Georgi", S., Plovdiv, B., & Popova, S. (2021) · Journal of IMAB - Annual Proceeding (Scientific Papers) · doi:10.5272/jimab.2021274.4170
Cosman, F., & Dempster, D. W. (2011) · Elsevier eBooks · doi:10.1016/b978-0-323-06551-1.00195-0
Osteoporosis: Pathophysiology and Clinical Aspects
Mikosch, P. (2016) · Springer eBooks · doi:10.1007/978-3-319-34238-2_7
Kerschan‐Schindl, K., Nebot, E., & Pietschmann, P. (2019) · Springer eBooks · doi:10.1007/978-3-319-99375-1_153 · Cited by 1
Kirk, B., Zanker, J., Phu, S., & Duque, G. (2021) · Wiley eBooks · doi:10.1002/9781119597896.ch11
Intermittierende PTH-Applikation zur Osteopenie-Therapie im weiblichen Rattentiermodell
Simon, B. F. (2018) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-6774 · Cited by 1
Faculty Opinions recommendation of Osteoporosis: now and the future.
Elisaf, M., & Rizos, C. V. (2013) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.717991070.793473318
Meyer, T. L. (2014) · Wiley eBooks · doi:10.1002/9783527682423.ch53
Osteoblasts in Human Skeletal Diseases
Findlay, D. M. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.11174-2
Chiappelli, F. (2011) · Springer eBooks · doi:10.1007/978-1-4419-9495-0_2
Use of Bone Biomarkers After Weight Loss: Example of Bariatric Surgery
Biagioni, M., Mendes, A. L., de Paiva, S. A. R., & Mazeto, G. M. F. D. S. (2017) · Biomarkers in disease · doi:10.1007/978-94-007-7693-7_8
Monroe, D. G., & Khosla, S. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-814841-9.00035-x
Self-citation(2018) · Elsevier eBooks · doi:10.1016/b978-3-437-22102-6.00004-4
Mazanec, D. J., Khalaf, T. M., & Orr, R. D. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-40030-5.00103-9
Martín, A. G., Bolívar, V. C., Sevilla, J. E., & Torres, M. M. (2022) · Medicine - Programa de Formación Médica Continuada Acreditado · doi:10.1016/j.med.2022.06.012
Osteoimmunology: Relation to Disease and Therapy
Weitzmann, M. N., & Pacifici, R. (2012) · Springer eBooks · doi:10.1007/978-1-4471-2745-1_14
“Pathological T cell and B cell activation is central to the pathogenesis of multiple disorders associated with bone loss, including postmenopausal osteoporosis [ 18, 21, 78– 80 ] , rheumatoid arthritis [ 17, 38, 68 ] , periodontitis [ 32, 36, 72 ] , cancer-induced bone loss [ 24 ] , and hyperparathyroidism [ 5, 23 ] .”
BackgroundRufato, F. C. T. (2021) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.58.2021.tde-27052022-100908 · Cited by 1
Billington, E. O., & Reid, I. R. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13825-6.00043-1
Effects of Growth Hormone on Osteoarthritis Development
Sun, L., Gang, X., Li, F. Y., Guo, W., Cui, M., & Wang, G. (2024) · Hormone and Metabolic Research · doi:10.1055/a-2411-9344 · Cited by 1
The Management of Osteoporosis in Children
Ward, L. M., Wang, M., & Ma, J. (2024) · Springer eBooks · doi:10.1007/978-3-031-66296-6_23
RANK LIGAND-OSTEOPROTEGERIN SYSTEM AS A DIAGNOSTIC TOOL IN OSTEOPOROSIS
Saccomanno, S., Bove, F., Greco, F., Bove, G., Guercio, E., Bove, G., Garcia-Godoy, F., & Prosperi, D. (2025) · BULLETIN OF STOMATOLOGY AND MAXILLOFACIAL SURGERY · doi:10.58240/1829006x-2025.21.4-255
Research Progress in the Etiology of Primary Osteoporosis
武, 晓. (2025) · Journal of Clinical Personalized Medicine · doi:10.12677/jcpm.2025.43354
Zhang, Y., Zheng, H., Li, Y., Wang, Y., & Zhang, L. (2025) · iScience · doi:10.1016/j.isci.2025.113720 · Cited by 1
Hu, Y., Chen, Z., Hu, S., Zhou, C., Chen, X., Wei, S., Wang, D., Liang, K., Wu, P., Chen, L., et al. (2025) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2025.178377
Bioactive Glass Modified by Sonochemistry Improves Peri-Implant Bone Repair in Ovariectomized Rats
Gomes, M. B., Duarte, N. D., Mulinari‐Santos, G., Batista, F. R. D. S., Costa, L. D. A., Botacin, P. R., Lisboa‐Filho, P. N., & Okamoto, R. (2025) · Biomimetics · doi:10.3390/biomimetics10120821
“…in early menopause also exhibit marked elevations in RANKL, expressed by osteoblasts, bone marrow stromal cells, and immune cells such as T and B lymphocytes, which binds to its receptor RANK on osteoclast precursors to drive differentiation, multinu-cleation, activation, and bone resorption [6].”
Mecanismos fisiopatogénicos involucrados en la patología ósea de la Enfermedad de Gaucher
Mucci, J. M. (2014) · El Servicio de Difusión de la Creación Intelectual (National University of La Plata) · doi:10.35537/10915/44681
Pharmacotherapy Options in Cancer Treatment-induced Bone Loss: Focus on Bisphosphonates
Ito, K. (2009) · Clinical Medicine Therapeutics · doi:10.4137/cmt.s2064
Osteoporosi: la scienza di base, inquadramento, classificazione
Tarantino, U., Cerocchi, I., & Andréoli, A. (2006) · Springer eBooks · doi:10.1007/978-88-470-0546-4_2
“Recentemente e stato dimostrato che un anticorpo monoclonale contro il RANKL provoca un’inibizione prolungata del riassorbimento osseo in donne in eta post-menopausale [ 37 ].”
BackgroundCharacterisation of cytokine expression in early synovitis and established rheumatoid arthritis
Yeo, L. (2012) · University of Birmingham Institutional Research Archive (University of Birmingham) · Cited by 1
Prevention and treatment of osteoporosis: causal or symptomatic?
Jan, Š. (2019) · Clinical Osteology · doi:10.36290/clo.2019.012 · Cited by 1
Zhou, C., Tao, J., Zhang, J., Yu, Y.-F., Ouyang, X., Li, R.-H., Deng, X.-S., Li, M., Qing, J., Liu, H.-P., et al. (2026) · International Immunopharmacology · doi:10.1016/j.intimp.2026.116487 · Cited by 2
Chronic low-grade inflammation and primary osteoporosis
Štěpán, J. (2025) · Clinical Osteology · doi:10.36290/clo.2025.023
Rôle de miR-146a dans la régulation des fonctions monocytaires dans l’arthrite
Ammari, M. (2014) · theses.fr (ABES) · doi:10.70675/d8f273e7za76fz4563z8757z7ef508bd461c
Metadata
- Authors
- Eghbali-Fatourechi, G., Khosla, S., Sanyal, A., Boyle, W. J., Lacey, D. L., & Riggs, B. L.
- Affiliations
- Mayo Clinic (US)
- Amgen (United States) (US)
- Corresponding author
- Riggs, B. Lawrence
- Venue
- Journal of Clinical Investigation
- Published
- 2003-04-15
- Volume
- 111
- Issue
- 8
- Pages
- 1221-1230
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC152939
- OpenAlex
- W4254761345
- Cited by
- 825
- References
- 44
- Citations by year
- 2026: 16 · 2025: 24 · 2024: 28 · 2023: 25 · 2022: 34 · 2021: 36 · 2020: 41 · 2019: 30 · 2018: 39 · 2017: 39 · 2016: 33 · 2015: 45 · 2014: 31 · 2013: 42 · 2012: 52
- FWCI
- 11.38
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Amgen
- National Institutes of Health (M01-RR00 585, AG 04875, RR-00585)
- U.S. Public Health Service (AG-04875)
- National Institute on Aging (P01-AG04875, P01AG004875)
- National Center for Research Resources (M01-RR00 585, M01RR000585)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Keywords
- RANK ligand, bone resorption, postmenopausal osteoporosis, estrogen deficiency, osteoclastogenesis, mesenchymal stem cells, T cells, B cells, osteoprotegerin, estradiol, bone turnover markers, paracrine signaling
- MeSH terms
- Adult, Bone Resorption, Carrier Proteins, Female, Flow Cytometry, Glycoproteins, Humans, Membrane Glycoproteins, Middle Aged, Tumor Necrosis Factor-alpha, Osteoporosis, Postmenopausal, Receptors, Tumor Necrosis Factor, Receptors, Cytoplasmic and Nuclear, Apoptosis Regulatory Proteins, TNF-Related Apoptosis-Inducing Ligand, Osteoprotegerin, RANK Ligand, Receptor Activator of Nuclear Factor-kappa B
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.